Atıf Formatları
Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. P. ERGENEKON Et Al. , "Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen," PEDIATRICS INTERNATIONAL , vol.64, no.1, 2022

ERGENEKON, A. P. Et Al. 2022. Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen. PEDIATRICS INTERNATIONAL , vol.64, no.1 .

ERGENEKON, A. P., YILMAZ YEĞİT, C., Cenk, M., GÖKDEMİR, Y., ERDEM ERALP, E., ÖZTÜRK, G., ... ÜNVER, O.(2022). Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen. PEDIATRICS INTERNATIONAL , vol.64, no.1.

ERGENEKON, ALMALA Et Al. "Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen," PEDIATRICS INTERNATIONAL , vol.64, no.1, 2022

ERGENEKON, ALMALA P. Et Al. "Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen." PEDIATRICS INTERNATIONAL , vol.64, no.1, 2022

ERGENEKON, A. P. Et Al. (2022) . "Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen." PEDIATRICS INTERNATIONAL , vol.64, no.1.

@article{article, author={ALMALA PINAR ERGENEKON Et Al. }, title={Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen}, journal={PEDIATRICS INTERNATIONAL}, year=2022}